Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Vivos Therapeutics, Inc. (VVOS) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/15/2023 4 Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.
Txns: Bought 10,000 shares @ $0.49, valued at $4.9k
12/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/28/2022 4 Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.
Txns: Granted 125,000 options to buy @ $3.27, valued at $408.8k
02/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/22/2021 4 Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.
Txns: Bought 5,000 shares @ $4.31, valued at $21.6k
09/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2021 4 Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.
Txns: Bought 5,000 shares @ $3, valued at $15k
08/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2021 4 Green Ralph Elias (Director) has filed a Form 4 on Vivos Therapeutics, Inc.
Txns: Granted 30,000 options to buy @ $2.72, valued at $81.6k
08/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/10/2021 4 Singh Gurdev Dave (Chief Medical Officer) has filed a Form 4 on Vivos Therapeutics, Inc.
Txns: Granted 30,000 options to buy @ $2.72, valued at $81.6k
08/10/2021 4 Lindsay Mark F. (Director) has filed a Form 4 on Vivos Therapeutics, Inc.
Txns: Granted 30,000 options to buy @ $2.72, valued at $81.6k
08/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/25/2021 4 Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.
Txns: Bought 4,000 shares @ $5.38, valued at $21.5k
03/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2020 4 Amman Bradford K. (CFO) has filed a Form 4 on Vivos Therapeutics, Inc.
Txns: Bought 1,000 shares @ $7.38, valued at $7.4k
12/23/2020 4 Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.
Txns: Bought 1,000 shares @ $7.2669, valued at $7.3k
12/14/2020 4 Huntsman Ronald Kirk (CEO) has filed a Form 4 on Vivos Therapeutics, Inc.
Txns: Bought 500 shares @ $8.5, valued at $4.3k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy